Bone Diseases, Metabolic: all 487 studies
Page 5 of 5. Open to participants first (74), then studies with results posted, then the rest; newest registration first within each.
- The Effect of 16 Weeks of Hip Adduction and Abduction Resistance ExerciseCompletedNCT01228877Not applicable
- Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium RanelateCompletedNCT01222026Phase 4
- Risedronate Therapy in the Treatment of Low Bone Mineral Density in Crohn's DiseaseCompletedNCT01215890Phase 4
- The Erlangen Fitness and Prevention Study (EFOPS).CompletedNCT01177761Not applicable
- Creatine Supplementation and Bone MassCompletedNCT01163370Not applicable
- A Comparison of Changes in Bone Density With the Same Bone-health Plan, But With Different Bone-health SupplementsCompletedNCT01114685Not applicable
- Improving Low Bone Mass With Vibration Therapy in Adolescent Idiopathic Scoliosis (AIS)CompletedNCT01108211Phase 3
- Study of an Intervention to Improve Problem List Accuracy and UseStatus unknownNCT01105923Not applicable
- An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral DensityCompletedNCT01101048Phase 1
- Using Ca-41 Methodology to Assess the Impact of Different Vitamin D Supplementation Levels on Postmenopausal Bone HealthCompletedNCT01053481Early Phase 1
- The Effect of Physical Activity on Bone Mineralization and Immune System in Very Low Birth Weight InfantsStatus unknownNCT01042639Not applicable
- Laparoscopic Revision From Biliopancreatic Diversion to Gastric BypassCompletedNCT01041456
- Tai Chi for Osteopenic WomenStatus unknownNCT01039012Phase 2
- A Cross-sectional Study to Investigate the Effect of Topiramate on Bone and Mineral Metabolism in Female Participants With EpilepsyCompletedNCT01030094
- Temporomandibular Disorders and OsteoporosisCompletedNCT01029210
- Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone HomeostasisCompletedNCT01020045
- Bone Loss After Laparoscopic Roux-en-Y Gastric BypassCompletedNCT00975013
- Wiser Choices in Osteoporosis Choice II: A Decision Aid for Patients and CliniciansCompletedNCT00949611Not applicable
- Study of Bone Disease in Older HIV-infected AdultsCompletedNCT00935935
- A First-in-human Study Evaluating AMG 167 in Healthy Men and Postmenopausal WomenCompletedNCT00902356Phase 1
- Proton Pump Inhibitor Therapy and Bone Density in Premature InfantsTerminatedNCT00888017
- Relationships Between Quality of Ageing and Age-related Degenerated Disease (Compalimage)Status unknownNCT00862615Not applicable
- Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast CancerCompletedNCT00859703Phase 3
- Awareness to Osteopenia's Treatment by Bisphosphonate in Male Suffering From Prostate CancerCompletedNCT00816452
- Zoledronate for Osteopenia in Pediatric Crohn'sCompletedNCT00798473Phase 3
- Nursing-Home Residents Given Bread Fortified With Vitamin D3CompletedNCT00789503Phase 1/2
- Investigating the Effect of Standardized Olive Extract on Bone Turnover Markers in Postmenopausal WomenCompletedNCT00789425Phase 2
- Can Risedronate Prevent Periprosthetic Bone Loss After Total Hip ArthroplastyCompletedNCT00772395Phase 4
- A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients.CompletedNCT00738257Phase 4
- Calciuric Effect and Cyclic Parenteral Nutrition in Preterm InfantsTerminatedNCT00711763
- Efficacy of Pamidronate in the Treatment of Bone Loss Associated With Liver TransplantCompletedNCT00657852Phase 4
- The Effect of Exercise in Postmenopausal Women with Low Bone DensityCompletedNCT00643331Phase 2
- A Preliminary Study of Bone Density in NeonatesCompletedNCT00631397
- Third Year Evaluation on Genistein Efficacy and SafetyCompletedNCT00626769
- Study to Evaluate Effect of Intranasal Teriparatide on Bone Mineral Density in Postmenopausal Women With Low BMDWithdrawnNCT00624481Phase 2
- Age Related Changes in Calciotropic Hormones and Their Impact on Male OsteoporosisCompletedNCT00588874
- Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal WomenCompletedNCT00578981Not applicable
- Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral DoseCompletedNCT00577850Phase 1
- Hormonal and Bone Turnover Marker Response to an Acute Bout of Resistance or Plyometric ExerciseCompletedNCT00572871
- Efficacy of Plyometrics to Increase Bone Mass in Men With OsteopeniaCompletedNCT00572104Not applicable
- A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia.CompletedNCT00545207Phase 3
- Effects of Hesperidin on Bone Biomarkers in Postmenopausal WomenCompletedNCT00545116Phase 2
- Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or OsteoporosisCompletedNCT00532337Phase 2
- Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant RecipientsTerminatedNCT00504218
- High Dosage Vitamin D and OsteoporosisCompletedNCT00491920Phase 4
- Comparison of Bone Effects With Copaxone and Interferon in Multiple SclerosisCompletedNCT00490906
- Osteoporosis Prevention With Low Dose AlendronateCompletedNCT00463268Phase 3
- Comparison of Tibolone and Raloxifene on Bone Mineral Density in Osteopenic Postmenopausal Women (P06090)CompletedNCT00431431Phase 4
- The Influence of Vibration on Bone Mineral Density in Women Who Have Weak Bones After MenopauseCompletedNCT00420940Phase 3
- "VIBES"--Low Magnitude Mechanical Stimulation to Improve Bone Mineral DensityCompletedNCT00396994Not applicable
- Vascular and Skeletal Protective Effects of Genistein in Postmenopausal WomenCompletedNCT00355953Phase 2/3
- Risedronate in Postmenopausal Women With Low Bone DensityCompletedNCT00351091Phase 2
- Effects of Hesperidin on Bone Mineral Density and Bone Metabolism of Postmenopausal WomenCompletedNCT00330096Phase 3
- 3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal WomenCompletedNCT00310531Phase 3
- Alendronate Osteoporosis StudyCompletedNCT00277251Phase 2/3
- A Taiwan Isoflavone Multicenter Study (TIMS)Status unknownNCT00262184Not applicable
- Isoflavones for Promoting Calcium Absorption and Preventing Bone Loss in Post Menopausal WomenCompletedNCT00244907Phase 1
- Osteoporosis and Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00231127
- Optimal Management of Women With Wrist FracturesCompletedNCT00226031Not applicable
- Fosamax Bone Loss Study: Alendronate to Prevent Bone LossCompletedNCT00221312
- FREE Study - Fracture Reduction EvaluationCompletedNCT00211211Phase 4
- Network Osteoporosis StudyStatus unknownNCT00209469Phase 2/3
- Effect of Exercise Training and Soy-based Nutritional Supplementation on Prevention of OsteoporosisCompletedNCT00204425Phase 3
- Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate CancerCompletedNCT00181584Phase 2
- What is the Best Policy to Prevent Osteoporotic Fracture?WithdrawnNCT00173693Not applicable
- Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis.CompletedNCT00170911Phase 2
- Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study)CompletedNCT00168909Phase 4
- Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss PreventionCompletedNCT00164008Phase 4
- Study to Investigate if Adding Lactulose to Vitamin D and Calcium Has an Effect on the Preservation of Bone in Postmenopausal WomenCompletedNCT00160264Phase 4
- Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis PatientsCompletedNCT00157690Phase 4
- Bone Mineral Density (BMD) in HIV InfectionTerminatedNCT00146094Not applicable
- To Assess the Efficacy of Over-the-counter Analgesics in the Prevention/Treatment of Transient Post-dose Symptoms Following Zoledronate Infusion in Post-menopausal WomenCompletedNCT00145275Phase 3
- Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral DensityWithdrawnNCT00117260Phase 3
- Osteopenia and Renal Osteodystrophy: Evaluation and ManagementCompletedNCT00108394Phase 4
- Bisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral DensityStatus unknownNCT00102908Phase 2
- Evaluation and Treatment of Patients With Connective Tissue DiseaseCompletedNCT00076830
- A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and YouthCompletedNCT00069004
- Electromagnetic Treatment For Bone Loss After Forearm FractureCompletedNCT00067834Phase 1/2
- Once Weekly Parathyroid Hormone for OsteoporosisCompletedNCT00065637Phase 3
- Bone Response to Soy Isoflavones in WomenCompletedNCT00043745Phase 2
- Nitroglycerin Ointment for Preventing Bone Loss in Postmenopausal WomenCompletedNCT00043719Phase 3
- Encouraging Calcium Absorption and Bone Formation During Early PubertyCompletedNCT00022867Phase 1/2
- Bone Loss in Premenopausal Women With DepressionCompletedNCT00006180Phase 4
- Diagnostic Pilot Study of Dual Energy Absorptiometry in the Detection of Osteopenia or Osteoporosis in Patients With Thalassemia MajorCompletedNCT00006138
- Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's DiseaseCompletedNCT00004488Phase 2
- Use of Bone Biopsy to Better Understand the Causes of Decreased Bone Mineral Density in DepressionCompletedNCT00001916
- Low-Dose Hormone Replacement Therapy and Alendronate for OsteoporosisTerminatedNCT00000430Phase 3